Huaxia Eye Hospital GroupLtd Past Earnings Performance
Past criteria checks 5/6
Huaxia Eye Hospital GroupLtd has been growing earnings at an average annual rate of 21.1%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 21% per year. Huaxia Eye Hospital GroupLtd's return on equity is 11.9%, and it has net margins of 16.5%.
Key information
21.1%
Earnings growth rate
18.2%
EPS growth rate
Healthcare Industry Growth | 7.0% |
Revenue growth rate | 21.0% |
Return on equity | 11.9% |
Net Margin | 16.5% |
Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Recent updates
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Dividend Is Being Reduced To CN¥0.11
Jul 12Huaxia Eye Hospital GroupLtd (SZSE:301267) Has Some Way To Go To Become A Multi-Bagger
Jun 06Analysts Just Shaved Their Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) Forecasts Dramatically
May 01Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly
Feb 29Revenue & Expenses Breakdown
How Huaxia Eye Hospital GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 4,061 | 672 | 1,027 | 72 |
31 Dec 23 | 4,013 | 666 | 998 | 70 |
30 Sep 23 | 3,813 | 674 | 933 | 75 |
30 Jun 23 | 3,648 | 632 | 867 | 69 |
31 Mar 23 | 3,355 | 552 | 786 | 56 |
01 Jan 23 | 3,233 | 514 | 762 | 49 |
30 Sep 22 | 3,297 | 516 | 762 | 47 |
01 Jan 22 | 3,064 | 455 | 717 | 25 |
30 Sep 21 | 2,998 | 445 | 675 | 22 |
31 Dec 20 | 2,515 | 334 | 591 | 20 |
31 Dec 19 | 2,456 | 218 | 682 | 19 |
31 Dec 18 | 2,146 | 164 | 621 | 14 |
31 Dec 17 | 1,543 | 78 | 495 | 11 |
Quality Earnings: 301267 has high quality earnings.
Growing Profit Margin: 301267's current net profit margins (16.5%) are higher than last year (16.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301267's earnings have grown significantly by 21.1% per year over the past 5 years.
Accelerating Growth: 301267's earnings growth over the past year (21.7%) exceeds its 5-year average (21.1% per year).
Earnings vs Industry: 301267 earnings growth over the past year (21.7%) exceeded the Healthcare industry -3.5%.
Return on Equity
High ROE: 301267's Return on Equity (11.9%) is considered low.